Physician

Waleed H Doghmi, M.D.

According to 2025 Medicare claims, Waleed Doghmi, M.D. (NPI: 1023010204) practices cardiology in the Midland, MI market, with the plurality of this provider's patient population coming from Midland, MI. This provider's primary affiliated billing organization is MYMICHIGAN MEDICAL CENTER MIDLAND (NPI: 1205889490; TIN: 380833014) and primary practice location at 48670-0001. Doghmi is affiliated with the POM ACO (ACO ID: A1297) and McLaren High Performance Network, LLC (ACO ID: A3317), participating under the MSSP model.

Doghmi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,113 traditional Medicare patients, billed 5,644 HCPCS/CPT codes, and received $134,942 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 6,455 prescription claims across 995 beneficiaries totaling $1,453,202 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 71 claims. Open Payments data shows 1 records totaling $495,278. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $82,441 to $1,453,202. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,258	3,764	$136,347
2016	1,533	4,476	$155,065
2017	1,964	4,408	$147,522
2018	2,778	5,499	$156,408
2019	3,069	5,788	$163,585
2020	2,520	4,835	$147,192
2021	2,513	4,728	$155,769
2022	3,219	5,748	$154,837
2023	3,666	6,603	$146,295
2024	3,113	5,644	$134,942

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	212	1,027	$82,441
2016	268	1,631	$152,686
2017	343	2,156	$195,789
2018	266	954	$127,630
2019	184	926	$155,264
2020	380	1,926	$327,798
2021	582	3,092	$581,396
2022	719	4,056	$762,995
2023	861	5,607	$1,142,107
2024	995	6,455	$1,453,202

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	105	$40,791
2017	N/R	71	$3,996
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	342	387	$49
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	827	862	$48
93016	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician	153	153	$14
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	171	171	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	2,059	2,716	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	473	34,967	$646,317
Repatha Sureclick	Evolocumab	228	10,189	$189,733
Jardiance	Empagliflozin	116	8,953	$167,448
Entresto	Sacubitril/Valsartan	95	6,928	$147,036
Xarelto	Rivaroxaban	78	6,150	$108,818

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$495,278	Midmichigan Medical Ctr
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Waleed H. Doghmi, M.D.?

Tedicare shows public-source Medicare data for Waleed H. Doghmi, M.D. (NPI 1023010204), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Waleed H. Doghmi, M.D. have ACO affiliation data?

Waleed H. Doghmi, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297) and McLaren High Performance Network, LLC (MSSP, ACO ID A3317).

What billing organization is linked to Waleed H. Doghmi, M.D.?

Waleed H. Doghmi, M.D. is linked to MYMICHIGAN MEDICAL CENTER MIDLAND (billing NPI 1205889490) in the available physician profile data.

Does Waleed H. Doghmi, M.D. have Open Payments data?

Waleed H. Doghmi, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.